期刊文献+

bcl-2 RNAi表达载体的构建、鉴定及其对Raji细胞的干扰效果 被引量:1

Construction, Identification of Bcl-2 RNAi Expression Plasmid and Interference Effects on Raji Cells
原文传递
导出
摘要 目的构建bcl-2特异性RNAi真核细胞质粒表达载体,并研究其对B细胞淋巴瘤Raji细胞的干扰效果。方法根据GenBank提供的bcl-2cDNA序列,设计并合成两对短发夹结构的互补DNA序列,经退火形成互补双链,克隆至载体pGenensil-1构建重组质粒,予以酶切和DNA测序鉴定。脂质体介导重组质粒转染Raji细胞,采用RT-PCR法观察重组质粒对bcl-2mRNA表达的影响,流式细胞仪测定细胞凋亡。结果酶切及测序鉴定表明,成功构建bcl-2shRNA的质粒表达载体pGenesil-1-bcl-2-544和pGenesil-1-bcl-2-1009。转染Raji细胞48h后,RT-PCR结果显示Raji细胞中bcl-2mRNA表达分别下调了(31.95±3.02)%和(47.57±2.88)%,与空白对照组相比,差异有统计学意义(P<0.05);流式细胞仪检测结果显示Raji细胞凋亡率分别为(14.25±0.84)%和(11.96±0.79)%,明显高于对照组,差异有统计学意义(P<0.05)。结论成功构建bcl-2特异性RNAi真核细胞质粒表达载体,它能有效沉默bcl-2基因在B细胞淋巴瘤中的表达并促进B细胞淋巴瘤Raji细胞凋亡。 Objective To construct short hairpin RNA (shRNA) interfering eukaryotic expression plasmid vector specific to bcl-2 gene and detect the interfering effects on B-lymphoma Raji cell. Methods Two pairs of complementary shDNA sequence were designed and synthesized according to bcl-2 eDNA from GenBank. After annealing, complementary double strands were formed and cloned into pGenesil-I vector to construct recombinant plasmids, which were identified by restriction enzyme digestion and DNA sequence analysis. Recombinant plasmids were transfected into Raji cells mediated by lipofectamineTM 2000, then bcl-2 mRNA expression and cell apoptotic rate was detected by RT-PCR and flow eytometry respectively. Results The results of restriction enzyme digestion and sequence analysis showed that pGenesil-l-bcl-2-544 and pGenesil-1-bc]-271009 plasmid vectors specific to bcl-2 shRNA were successfully constructed. At the forty-eighth hour post-transfection, bcl-2 mRNAs expression of Raji cells were reduced to (31.95±3.02)% and (47.57±2.88)% in pGenesil-1-bcl-2-544 group and pGenesil-1-bc1-2-1009 group respectively. Compared with the control group, statistically significant difference was observed (P〈0.05). The ratio of apoptosis cells were (14.25±0.84) % and (11. 96±0.79)% in pGenesil-1-bel-2-544 group and pGenesil-1-bel-2-1009 group respectively, which was significantly higher than that in the control group(P〈0.05). Conclusion The eukaryotic shRNA plasmid expression vectors specific to bcl-2 gene were successfully constructed, which can silence bcl-2 gene and induce apoptosis effectively on B cell lymphoma.
出处 《苏州大学学报(医学版)》 CAS 北大核心 2009年第3期406-410,共5页 Suzhou University Journal of Medical Science
基金 国家自然科学基金资助项目(30400111) 江苏省自然科学基金资助项目(BK2004041) 苏州市科教兴卫青年科技项目(SWKQ0811)
关键词 RNAI BCL-2 B细胞淋巴瘤 RAJI细胞 pGenesil-1载体 RNAi bcl-2 B-lymphoma Raji cell pGenesil-1 vector
  • 相关文献

参考文献5

二级参考文献71

  • 1闵大六,夏海龙,周晓燕,孙孟红,杨文涛,张太明,郑爱华,施达仁.弥漫大B细胞淋巴瘤组织bcl-6蛋白表达及基因重排[J].中华病理学杂志,2005,34(6):327-331. 被引量:4
  • 2Bohula E A, Salisbury A J, Sohail M, et al. The efficacy of small interfering RNAs targeted to the type 1 insulin-like growth factor receptor (IGF1R) is influenced by secondary structure in the IGF1R transcript. J Biol Chem, 2003, 278(18): 15991~15997
  • 3Tuschl T, Borkhardt A. Small interfering RNAs: a revolutionary tool for the analysis of gene function and gene therapy.Mol Intervent, 2002, 2(3): 158-167
  • 4Miyagishi M, Taira K. U6 promoter-driven siRNAs with four uridine 3'overhangs efficiently suppress targeted gene expression in mammalian cells. Nat Biotech, 2002,19:497-500
  • 5Lee N S, Dohjima T, Bauer G, et al. Expression of small interfering RNAs targeted against HIV-1 rev transcripts in human cells. Nat Biotech, 2002, 19:500-505
  • 6Paul C P, Good P D, Winer I, et al. Effective expression of small interfering RNA in human cells. Nat Biotech, 2002,19:505-508
  • 7Castanotto D, Li H T, Rossi J J. Functional siRNA expression from transfected PCR products. RNA, 2002, 8:1454-1460
  • 8Kumar R, Conklin D S, Mittal V. High-throughput selection of effective RNAi probes for gene silencing. Genome Res,2003, 13:2333-2340
  • 9Boden D, Pusch O, Lee F, et al. Promoter choice affects the potency of HIV- 1 specific RNA interference. Nucl Acid Res,2003, 31(17): 5033-5038
  • 10Barton G M, Medzhitov R. Retroviral delivery of small interfering RNA into primary cells. Proc Natl Acad Sci USA,2002, 99(23): 14943-14945

共引文献52

同被引文献9

  • 1Kim Y, Lin Q, Glazer PM, et al. Hypoxic tumor microenvironment and cancer cell differentiation [ J ]. Curr Mol Med, 2009, 9 (4) : 425 -434.
  • 2Dewhirst MW. Relationships between cycling hypoxia, HIF-1, angiogenesis and oxidative stress[J]. Radiat Res, 2009, 172(6) :653 -665.
  • 3Wang Y, Sun A, Xue J, et al. Bone marrow derived stromal cells modified by adenovirus-mediated HIF-lalpha double mutant protect cardiac myocytes against CoCl2-induced apoptosis [ J ]. Toxicol in Vitro, 2009, 23 ( 6 ) : 1069 - 1075.
  • 4Oliver L, Olivier C, Marhuenda FB, et al. Hypoxia and the malignant glioma microenvironment: regulation and implications for therapy [ J ]. Curr Mol Pharmacol, 2009,2 (3) :263 - 284.
  • 5Nardinocchi L, Puca R, Sacchi A, et al. Inhibition of HIF-1 alpha activity by homeodomain-interacting protein kinase-2 correlates with sensitization of chemoresistant cells to undergo apoptosis [ J]. Mol Cancer, 2009, 8 : 1.
  • 6Moeller B J, Richardson RA, Dewhirst MW. Hypoxia and radiotherapy: opportunities for improved outcomes in cancer treatment[ J ]. Cancer Metastasis Rev, 2007, 26 (2) : 241 - 248.
  • 7Arvold ND, Guha N, Wang D, et al. Hypoxia-induced radioresistance is independent of hypoxia-inducible factor-1 alpha in vitro [ J ]. Int J Radiat Oncol Biol Phys, 2005, 62 ( 1 ) :207 , 212.
  • 8Zou Y, Cheng C, Omura-Minamisawa M, et al. The suppression of hypoxia-inducible factor and vascular endothelial growth factor by siRNA does not affect the radiation sensitivity of muhicellular tumor spheroids [ J ]. J Radiat Res,2010, 51(1) :47 -55.
  • 9Vordermark D, Katzer A, Baier K, et al. Cell type-specific association of hypoxia-inducible factor-1 alpha ( HIF- 1 alpha) protein accumulation and radiobiologic tumor hypoxia[J]. Int J Radiat Oncol Biol Phys, 2004, 58 (4) : 1242 - 1250.

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部